Merck
HomeWebinarsLatest Advancements of Melt-based 3D Printing Technologies for Oral Drug Delivery

Latest Advancements of Melt-based 3D Printing Technologies for Oral Drug Delivery



WEBINAR

The application of polymer excipients in 3D printing manufacturing is usually limited due to the concerns of filament strength, high processing temperature and large-scale manufacturing. Latest technology developments are targeting a direct melt deposition to simplify the process and enable a constant and efficient process. Two different processing approaches will be presented: The advanced melt drop deposition, where individual three-dimensional geometries can be created by deposition of polymer droplets, and the MED® 3D printing technology which allows precise layer-by-layer deposition to produce objects with well-designed geometric structures.

In this webinar, you will learn:

  • Latest advancements of melt-based 3D printing approaches
  • Application examples for the individual technologies
  • Deep dive in the MED® 3D printing technology to design dedicated drug release profiles
  • Excipient requirements for 3D printing technology

Speakers

Thomas Kipping, Ph.D.

Thomas Kipping, Ph.D.

Merck

Head of Drug Carriers

With a broad expertise in the field of solid dosage forms, Dr. Thomas Kipping provides a deep understanding of formulation development and process optimization in the complex area of solubility enhancement. He has a strong background in pharmaceutical industry, including industrial development, GMP manufacturing, clinical supply and research & development. Thomas is a pharmacist by education and holds a Ph.D. in Pharmaceutical Technology.

Xianghao Zuo, Ph.D.

Xianghao Zuo, Ph.D.

Triastek, Inc.

Deputy Director of R&D

Xianghao Zuo received his Ph.D. in materials science and engineering at Stony Brook University. He is now the deputy director of R&D at Triastek, Inc., specializing in developing 3D-printed drug products and improving the solubility and bioavailability of poorly soluble drugs.